ASEAN Strengthens Medicine Supply Chains and Domestic Production
Published
Governments of ASEAN countries will strengthen monitoring of medicine supply chains and domestic production capacity. This measure aims to improve the resilience of the medicine supply chain against future disruptions. This information was reported by BMI and published on the KLSE Screener website.
According to the report, many countries in Southeast Asia still depend on imports of medicinal materials and products from abroad. Therefore, when production or transportation problems occur at the global level, the supply of medicines in the region may be affected. By monitoring the supply chain more carefully, governments can identify risks earlier and take appropriate action.
In addition, domestic medicine production is also a priority. Governments may encourage local companies to manufacture essential medicines, so that the public has more stable access to the medicines they need. This approach can also help enhance skills and investment in the pharmaceutical industry.
In conclusion, efforts to strengthen supply chains and domestic production are seen as important to ensure that medicines are always available throughout the ASEAN region, including in Malaysia. Further developments regarding the implementation of this measure need to be monitored in the future.
Sources: KLSE Screener
More Malaysia news
- Malaysian Stock Market Opens Higher After US Tech Stocks Recover
- Analysts: Malaysia's Tech Sector Faces Sentiment Decline, Not Earnings Impact
- Skilled Workforce Essential for Malaysia's Digital Transformation
- Malaysia Outlines Plans to Strengthen Digital Security and Improve Internet Connectivity
- Malaysia Targets One Million Affordable Homes Through Modular Construction Technology
- Two New Political Parties Emerge Amid Political Divisions in Malaysia
- Sabah PH Chairman Urges Parties Not to Use Religion as a Political Weapon
- Malaysia Wants Smoother Medical Claims Process